ANI PHARMACEUTICALS INC Earnings Per Share Diluted

• ANI PHARMACEUTICALS INC showed an increase of +419.2% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from ANI PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 27, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2013: $0.13 per share | Q1 2014: $0.33 per share | Q2 2014: $0.21 (loss) per share | Q3 2014: $0.59 per share | Q4 2014: $1.82 per share | Q1 2015: $0.38 per share | Q2 2015: $0.31 per share | Q3 2015: $0.39 per share | Q4 2015: $0.25 per share | Q1 2016: $0.12 per share | Q2 2016: $0.10 per share | Q3 2016: $0.22 per share | Q4 2016: $0.09 (loss) per share | Q1 2017: $0.10 per share | Q2 2017: $0.23 per share | Q3 2017: $0.40 per share | Q4 2017: $0.83 (loss) per share | Q1 2018: $0.19 per share | Q2 2018: $0.23 per share | Q3 2018: $0.42 per share | Q4 2018: $0.46 per share | Q1 2019: $0.04 per share | Q2 2019: $0.53 per share | Q3 2019: $0.32 per share | Q4 2019: $0.41 (loss) per share | Q1 2020: $0.59 (loss) per share | Q2 2020: $1.03 (loss) per share | Q3 2020: $0.04 per share | Q4 2020: $0.30 (loss) per share | Q1 2021: $0.01 per share | Q2 2021: $1.17 (loss) per share | Q3 2021: $0.37 (loss) per share | Q1 2022: $1.27 (loss) per share | Q2 2022: $0.94 (loss) per share | Q3 2022: $0.55 (loss) per share | Q1 2023: $0.06 per share | Q2 2023: $0.29 per share | Q3 2023: $0.45 per share | Q1 2024: $0.82 per share | Q2 2024: $0.14 (loss) per share | Q3 2024: $1.27 (loss) per share | Q1 2025: $0.69 per share | Q2 2025: $0.36 per share | Q3 2025: $1.13 per share.
• Over the full 17 years of available data (2009 to 2025), ANI PHARMACEUTICALS INC's Earnings Per Share Diluted has grown by 337.1%.
• Historical annual values: Fiscal year 2025: $3.32 per share | Fiscal year 2024: $1.04 (loss) per share | Fiscal year 2023: $0.85 per share | Fiscal year 2022: $3.05 (loss) per share | Fiscal year 2021: $3.40 (loss) per share | Fiscal year 2020: $1.88 (loss) per share | Fiscal year 2019: $0.50 per share | Fiscal year 2018: $1.30 per share | Fiscal year 2017: $0.09 (loss) per share | Fiscal year 2016: $0.34 per share | Fiscal year 2015: $1.32 per share | Fiscal year 2014: $2.59 per share | Fiscal year 2013: $0.92 (loss) per share | Fiscal year 2012: $1.27 (loss) per share | Fiscal year 2011: $3.15 (loss) per share | Fiscal year 2010: $4.21 (loss) per share | Fiscal year 2009: $1.40 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026